7 August 2024

pharmaceutical

NT looks to follow QLD’s lead on pharmacy

24 July 2024

Bullous Pemphigoid Paediatrics pharmaceutical

JAK inhibitor helps beat infantile bullous pemphigoid

12 June 2024

Dermatitis/Eczema pharmaceutical

Call for calm over topical steroid withdrawal reports

15 May 2024

Media Pain pharmaceutical

Opioids on the silver screen

1 May 2024

Pain pharmaceutical

Under half of fibromyalgia patients use evidence-based drugs

1 May 2024

pharmaceutical Public Health

Fresh call to up-schedule modified-release paracetamol

1 May 2024

Atopic Dermatitis pharmaceutical Psoriasis

PBAC tick for new psoriasis, HS and AD options

17 April 2024

Acne pharmaceutical

Derms prescribe the most antibiotics: US study

17 April 2024

Allergies pharmaceutical

Day-to-day protection against food allergy on the horizon

20 March 2024

Hidradenitis Suppurativa pharmaceutical

New BTK inhibitor shows promise in hidradenitis suppurativa

6 March 2024

pharmaceutical

Oral morphine substitute approved

6 March 2024

pharmaceutical Urticaria

Can a new JAK inhibitor help urticaria?

7 February 2024

Neurology Pain pharmaceutical TGA Women

Watch for gabapentin skin reactions: TGA

29 November 2023

COVID-19 pharmaceutical

Covid curbed antimicrobial use, but for how long?

15 November 2023

pharmaceutical psoriatic arthritis

Anti-JAKs safe in skin conditions

2 November 2023

Paediatrics PBS pharmaceutical

PBS cuts etanercept red tape